0.00Open0.20Pre Close0 Volume34 Open Interest120.00Strike Price0.00Turnover183.86%IV-0.23%PremiumJul 19, 2024Expiry Date0.48Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.1732Delta0.1181Gamma602.40Leverage Ratio-7.6214Theta0.0000Rho104.35Eff Leverage0.0030Vega
ESCO Technologies Stock Discussion
In reaction to earnings/guidance:
• $Planet Labs PBC(PL.US)$ +11.3%, $Core & Main(CNM.US)$ +6.1%, $Regal Rexnord(RRX.US)$ +2% (reaffirms outlook), $Oracle(ORCL.US)$ +1.6%
Other news:
• $Akero Therapeutics(AKRO.US)$ +93.2% (reports Phase 2b HARMONY Study)
• $Akouos(AKUS.US)$ +10.3% (FDA clears IND application to initiate a Phase 1/2 first in human pediatric clinical trial of AK-OTOF)
• $Catalyst Pharmaceuticals(CPRX.US)$ +7.7...
No comment yet